Researcher
Steven Ballet
- Keywords:Chemistry (incl. biochemistry)
- Disciplines:Medicinal chemistry, Synthesis of materials, Characterisation of biologically active (macro)molecules, (Bio)molecular modelling and design, Bio-organic chemistry
Affiliations
- Organic Chemistry (Research group)
Responsible
From11 Mar 2021 → Today - Chemistry (Department)
Member
From1 Jan 2021 → Today - Chemistry (Department)
Member
From8 Apr 2019 → Today - Faculty of Sciences and Bioengineering Sciences (Faculty)
Member
From22 Jun 2017 → 7 Sep 2017 - Chemistry (Department)
Member
From1 Oct 2010 → 20 Oct 2022 - Chemistry (Department)
Member
From1 Jan 2003 → 30 Sep 2011
Infrastructure
1 - 2 of 2
Projects
11 - 20 of 31
- Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases.From1 Mar 2020 → TodayFunding: H2020-EU.1.2.- EXCELLENT SCIENCE - Future and Emerging Technologies (FET)
- P-STAC: Stabilizing Peptide nanoStructures with tetraThiofulvalenebased donors and ACceptorsFrom1 Jan 2020 → 31 Dec 2022Funding: FWO Prices and sabbaticals (before FWO undefined)
- G protein-signaling biased ligands of the µ-opioid receptors for improved pain therapyFrom1 Nov 2019 → 31 Oct 2023Funding: FWO fellowships
- SRP-Onderzoekszwaartepunt: Exploiting Peptides: Protein Binders, Modulators and Inhibitors for Imaging and Therapy [Exploit-PeptIT]From1 Mar 2019 → TodayFunding: BOF - projects
- SMART BIOMATERIALS TOWARDS MINIMALLY INVASIVE BREAST RECONSTRUCTIONFrom1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
- Molecular engineering of peptide-based hydrogels for sustained drug releaseFrom1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
- IOF Proof of Concept: Development of dual acting drugs targeting biased Mu opioid agonism and neuropeptide FF antagonism for the treatment of actute and chronic painFrom21 Dec 2018 → 20 Dec 2020Funding: IOF - technology concept exploration
- Downsizing the downsized: Nanobody CDR peptidomimicryFrom1 Oct 2018 → 30 Sep 2022Funding: FWO fellowships
- SBO COMPLEXYS.COM: Nanobodies as allosteric modulators of transient protein complexes to innovate therapy and drug discoveryFrom1 Jul 2017 → 31 Dec 2019Funding: SBO (Strategic basic research)
- Interdisciplinary Network for Fundamental and Medical Research on Lung cancerFrom1 Jul 2016 → 30 Jun 2021Funding: University - Project driven research
Publications
1 - 10 of 85
- Introduction of constrained Trp analogs in RW9 modulates structure and partition in membrane models(2023)
Authors: Camille Lozada, S Gonzalez, Rémy Agniel, Mathilde Hindie, Luca Manciocchi, Liuba Mazzanti, Tap Ha-Duong, Federica Santoro, Alfonso Carotenuto, Steven Ballet, et al.
- Smart hydrogels delivered by high pressure aerosolization can prevent peritoneal adhesions(2023)
Authors: Helena Braet, Peter Paul Fransen, Yong Chen, Simon Van Herck, Remco Mariën, Valérie Vanhoorne, Wim Ceelen, Annemieke Madder, S Ballet, Richard Hoogenboom, et al.
Pages: 138-150 - Structure-Based Design and Synthesis of Stapled 10Panx1 Analogues for Use in Cardiovascular Inflammatory Diseases(2023)
Authors: Arthur Lamouroux, Malaury Tournier, Debora Iaculli, Anne Caufriez, Olga M Rusiecka, Charlotte Martin, Viviane Bes, Laureano E Carpio, Yana Girardin, Remy Loris, et al.
Pages: 13086-13102 - Identification of small molecule antivirals against HTLV-1 by targeting the hDLG1-Tax-1 protein-protein interaction(2023)
Authors: Sibusiso B Maseko, Yasmine Brammerloo, Inge Van Molle, Adrià Sogues, Charlotte Martin, Christoph Gorgulla, Estelle Plant, Julien Olivet, Jeremy Blavier, Thandokuhle Ntombela, et al.
Pages: 105675 - Determination of structural features that underpin the pannexin1 channel inhibitory activity of the peptide 10Panx1(2023)
Authors: Anne Caufriez, Arthur Lamouroux, Charlotte Martin, Debora Iaculli, Elif Ince Ergüç, Rafael Gozalbes, María Dolores Mayán Santos, Brenda R. Kwak, Andres Tabernilla Garcia, Mathieu Vinken, et al.
- Bypassing the Need for Cell Permeabilization(2023)
Authors: A Breine, K Van Holsbeeck, C Martin, S Gonzalez, M Mannes, Els Pardon, Jan Steyaert, H Remaut, S Ballet, C Van der Henst
Pages: 1234-1243 - Nanobody Loop Mimetics Enhance Son of Sevenless 1-Catalyzed Nucleotide Exchange on RAS(2023)
Authors: K Van Holsbeeck, Baptiste Fischer, S Gonzalez, Charlène Gadais, Wim Versées, José Martins, Charlotte Martin, Alexandre Wohlkönig, J Steyaert, S Ballet
Pages: 1-6 - Fast Self-Assembly Dynamics of a β-Sheet Peptide Soft Material(2023)
Authors: Jolien Bertouille, Sandor Kasas, Charlotte Martin, Ulrich Hennecke, Steven Ballet, Ronnie Willaert
- YbiB(2023)
Authors: Babette Deckers, Silke Vercauteren, Veerke De Kock, Charlotte Martin, Tamas Lazar, Pauline Herpels, Liselot Dewachter, Natalie Verstraeten, Eveline Peeters, Steven Ballet, et al.
Pages: 3420-3435 - Nature-Inspired Dual Purpose Strategy toward Cell-Adhesive PCL Networks: C(-linker-)RGD Incorporation via Thiol-ene Crosslinking(2023)
Authors: Quinten Thijssen, Laurens Parmentier, K Van Holsbeeck, S Ballet, Sandra Van Vlierberghe
Pages: 1638-1647
Patents
1 - 5 of 5
- Hydrogel-forming composition for controlled released (Inventor)
- Hydrogel-forming peptides (Inventor)
- G protein peptidomimetics (Inventor)
- Hydrogel-forming peptides (Inventor)
- G protein peptidomimetics (Inventor)